GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $50,000 | -99.9% | 235 | -56.1% | 0.00% | -100.0% |
| Q4 2020 | $34,650,000 | +18.6% | 535 | 0.0% | 0.10% | +630.8% |
| Q3 2020 | $29,227,000 | -20.7% | 535 | 0.0% | 0.01% | -40.9% |
| Q2 2020 | $36,844,000 | +40.1% | 535 | 0.0% | 0.02% | +22.2% |
| Q1 2020 | $26,291,000 | +62497.6% | 535 | +118.4% | 0.02% | – |
| Q2 2019 | $42,000 | -99.8% | 245 | +4.3% | 0.00% | -100.0% |
| Q4 2018 | $22,886,000 | -41.8% | 235 | 0.0% | 0.01% | -38.5% |
| Q3 2018 | $39,306,000 | +18.8% | 235 | 0.0% | 0.01% | +8.3% |
| Q2 2018 | $33,083,000 | +33.0% | 235 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $24,877,000 | -19.5% | 235 | 0.0% | 0.01% | -17.6% |
| Q4 2017 | $30,902,000 | -1.1% | 235 | -17.5% | 0.02% | -10.5% |
| Q3 2017 | $31,244,000 | -6.8% | 285 | -14.9% | 0.02% | -13.6% |
| Q2 2017 | $33,533,000 | +0.5% | 335 | +17.5% | 0.02% | +37.5% |
| Q1 2017 | $33,371,000 | +19.3% | 285 | +21.3% | 0.02% | -15.8% |
| Q4 2016 | $27,979,000 | – | 235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |